Correlation Between Monte Rosa and Merus BV
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Merus BV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Merus BV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Merus BV, you can compare the effects of market volatilities on Monte Rosa and Merus BV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Merus BV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Merus BV.
Diversification Opportunities for Monte Rosa and Merus BV
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Monte and Merus is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Merus BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merus BV and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Merus BV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merus BV has no effect on the direction of Monte Rosa i.e., Monte Rosa and Merus BV go up and down completely randomly.
Pair Corralation between Monte Rosa and Merus BV
Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 5.97 times more return on investment than Merus BV. However, Monte Rosa is 5.97 times more volatile than Merus BV. It trades about 0.11 of its potential returns per unit of risk. Merus BV is currently generating about -0.08 per unit of risk. If you would invest 582.00 in Monte Rosa Therapeutics on August 31, 2024 and sell it today you would earn a total of 454.00 from holding Monte Rosa Therapeutics or generate 78.01% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.44% |
Values | Daily Returns |
Monte Rosa Therapeutics vs. Merus BV
Performance |
Timeline |
Monte Rosa Therapeutics |
Merus BV |
Monte Rosa and Merus BV Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Monte Rosa and Merus BV
The main advantage of trading using opposite Monte Rosa and Merus BV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Merus BV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merus BV will offset losses from the drop in Merus BV's long position.Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
Merus BV vs. Anebulo Pharmaceuticals | Merus BV vs. Adagene | Merus BV vs. Acrivon Therapeutics, Common | Merus BV vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |